CVE:IBT IBEX Technologies (IBT) Stock Price, News & Analysis C$1.44 0.00 (0.00%) As of 04/5/2024 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About IBEX Technologies Stock (CVE:IBT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBEX Technologies alerts:Sign Up Key Stats Today's RangeC$1.44▼C$1.4450-Day RangeC$1.44▼C$1.4452-Week RangeC$0.75▼C$1.45Volume200 shsAverage Volume68,888 shsMarket CapitalizationC$35.54 millionP/E Ratio11.52Dividend Yield3.11%Price TargetN/AConsensus RatingN/A Company OverviewIBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.Read More… Remove Ads Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IBT Stock News HeadlinesSupplementary Review: IBEX Limited (IBEX), November 12, 2024November 13, 2024 | msn.comIBEX Announces Record First Quarter of Fiscal Year 2025 Financial ResultsNovember 7, 2024 | markets.businessinsider.comTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.April 2, 2025 | Priority Gold (Ad)ibex Launches Wave iX TranslateJuly 23, 2024 | tmcnet.comibex's Christy O'Connor Recognized as Top 10 Corporate Counsel Award WinnerMay 2, 2024 | tmcnet.comIBEX Completes Sale of the CompanyApril 8, 2024 | markets.businessinsider.comIBEX Technologies Inc.: IBEX Shareholders Approve Sale of the CompanyApril 4, 2024 | finanznachrichten.deIBEX Technologies Inc.March 23, 2024 | wsj.comSee More Headlines IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed this year? IBEX Technologies' stock was trading at C$1.44 at the beginning of the year. Since then, IBT shares have increased by 0.0% and is now trading at C$1.44. View the best growth stocks for 2025 here. How do I buy shares of IBEX Technologies? Shares of IBT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of IBEX Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that IBEX Technologies investors own include Aurora Cannabis (ACB), Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE) and Bank of Montreal (BMO). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:IBT CIKN/A Webwww.ibex.ca Phone+1-514-3444004FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C$0.12 Trailing P/E Ratio11.52 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.10 million Net Margins53.78% Pretax MarginN/A Return on Equity21.95% Return on Assets6.42% Debt Debt-to-Equity Ratio11.06 Current Ratio6.24 Quick Ratio4.93 Sales & Book Value Annual SalesC$5.77 million Price / Sales6.15 Cash FlowC$0.92 per share Price / Cash Flow1.56 Book ValueC$0.58 per share Price / Book2.48Miscellaneous Outstanding Shares24,677,792Free FloatN/AMarket CapC$35.54 million OptionableNot Optionable Beta-0.05 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (CVE:IBT) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IBEX Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.